Bruker (BRKR) Common Equity (2009 - 2026)

Bruker has reported Common Equity for 18 years, with the latest figure at $2.5 billion in Q1 2026.

• For the quarter ending Q1 2026, Common Equity rose 34.6% year-over-year to $2.5 billion; the trailing twelve-month figure through Mar 2026 stood at $2.5 billion (up 34.6% YoY), and the FY2025 full-year result was $2.5 billion, up 37.64% from the prior year.
• Common Equity for Q1 2026 stood at $2.5 billion, roughly flat from $2.5 billion in the prior quarter.
• The five-year high for Common Equity was $2.5 billion in Q4 2025, with the low at $948.0 million in Q3 2022.
• Historically, Common Equity has averaged $1.6 billion across 5 years, with a median of $1.4 billion in 2024.
• Annual changes were most pronounced in 2022 — Common Equity retreated 13.0% — and 2024, when it surged 48.73%.
• Bruker's Common Equity stood at $1.1 billion in 2022, then gained by 23.89% to $1.4 billion in 2023, then increased by 28.86% to $1.8 billion in 2024, then jumped by 37.64% to $2.5 billion in 2025, then retreated by 0.26% to $2.5 billion in 2026.
• The last three Common Equity figures came in at $2.5 billion (Q1 2026), $2.5 billion (Q4 2025), and $2.4 billion (Q3 2025), per Business Quant data.